New Drug Remdesivir found working against COVID19 clinical trial conducted on monkeys

Drug Remdesivir was found to protect rhesus macaques (monkeys).
Two group of 6 monkeys were formed and all 12 monkeys were infected with sars-cov-2 virus (ncov19) found that 6 monkeys which was given Remdesivir were protected from damaging effect of sars-cov-2 virus on lungs. While other group of monkeys which did not receive drug was reported to have difficulty in breathing and developed the COVID19 disease.

Drug Remdesivir suppose to be tested in higher number of multi center clinical trails involving COVID19 patients, drug Remdesivir designed to work against EBOLA virus, and it has shown good outcomes against EBOLA virus was tested in monkeys in 2015.

Drug Remdesivir dveloped by Gilead sciences, it is a product which get converted in body in to active adinosine nucleotide analog drug and inhibit formation of viral RNA thereby hampering the multiplication of virus.

Leave a Reply